<DOC>
	<DOC>NCT00119652</DOC>
	<brief_summary>The purpose of this study is to determine whether quetiapine is effective and safe in the acute treatment of bipolar depression and whether the effect is maintained when treatment is continued.</brief_summary>
	<brief_title>Seroquel in Bipolar Depression Versus SSRI</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>Male and female outpatients aged 18 to 65 years inclusive Diagnosis of Bipolar Disorder (Bipolar I or Bipolar II), most recent episode depressed Current period of depression lasting less than 4 weeks or more than 12 months Use of prohibited medication Substance or alcohol dependence or abuse Current suicide risk or suicide attempt within 6 months Breast feeding or pregnancy Clinically relevant disease or clinical finding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Bipolar disorder</keyword>
	<keyword>bipolar depression</keyword>
	<keyword>depression</keyword>
</DOC>